Companies seeking to register R&D Activities conducted during the Year Ended 31 December 2023 (companies that have a December Year End for tax) who are yet to do so should note that the Registration Deadline is the end of October 2024. The extensions granted during COVID no longer apply, and the statutory deadlines revert to normal (10 months after the end of a company’s financial year). There are mechanisms available under the IR&D Act and IRD Decision making provisions that allow for […]
The Queensland Government has announced that Round 7 grant applications for their Made in Queensland (MIQ) Grant will open on September 24th. MIQ offers grants up to $2.5 million for Queensland small to medium manufacturers. The program is designed to help manufacturers increase their international competitiveness, productivity and innovation, and generate high-skilled jobs for the future by purchasing and implementing new and advanced equipment or technologies as part of operations. Whilst companies that can attain grant funding should look […]
The ATO have provided some additional details on their upcoming R&D Tax Incentive transparency reporting. An ATO update circulated August 2024 notes: We’ll publish our first annual Report of data about Research and Development tax incentive entities in late September 2024. It will contain specific data about R&D entities that claimed the incentive for the 2021–22 income year. By providing transparency of how much R&D entities are reporting in R&D expenditure, the aim of the report is to improve public accountability […]
Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $2.6 M related to its anti-infective platform; Latrobe Magnesium (ASX: LMG) received $12.5 M related to Magnesium extraction technology; Group 6 Metals (ASX:G6M) received $14.3 M related to processes for producing higher value tungsten products Orthocell Limited (ASX: SNT) received $3.05 M related to its mobility regeneration technology; Botanix (ASX: BOT) received $3 […]